Selected article for: "acute phase and low molecular weight"

Author: Ciuca, Cristina; Fabi, Marianna; Di Luca, Daniela; Niro, Fabio; Ghizzi, Chiara; Donti, Andrea; Balducci, Anna; Rocca, Alessandro; Zarbo, Chiara; Gargiulo, Gaetano Domenico; Lanari, Marcello
Title: Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2
  • Cord-id: 9tvwtxyv
  • Document date: 2020_12_17
  • ID: 9tvwtxyv
    Snippet: A 6‐year‐old African boy with multi‐viral infection including parvovirus B19 and severe acute respiratory syndrome coronavirus 2 was admitted for persistent fever associated with respiratory distress and myocarditis complicated by cardiogenic shock needing ventilatory and inotropic support. Coronary aneurysms were also documented in the acute phase. Blood tests were suggestive of macrophage activation syndrome. He was treated with intravenous immunoglobulins, aspirin, diuretics, dexamethas
    Document: A 6‐year‐old African boy with multi‐viral infection including parvovirus B19 and severe acute respiratory syndrome coronavirus 2 was admitted for persistent fever associated with respiratory distress and myocarditis complicated by cardiogenic shock needing ventilatory and inotropic support. Coronary aneurysms were also documented in the acute phase. Blood tests were suggestive of macrophage activation syndrome. He was treated with intravenous immunoglobulins, aspirin, diuretics, dexamethasone, hydroxychloroquine, and prophylactic low molecular weight heparin. Normalization of cardiac performance and coronary diameters was noticed within the first days. Cardiac magnetic resonance imaging, performed 20 days after the hospitalization, evidenced mild myocardial interstitial oedema with no focal necrosis, suggesting a mechanism of cardiac stunning related to cytokines storm rather than direct viral injury of cardiomyocytes.

    Search related documents:
    Co phrase search for related documents
    • acute phase and long term therapy: 1
    • acute phase and low grade inflammation: 1, 2
    • acute phase and low molecular weight heparin: 1, 2, 3, 4, 5
    • acute phase and low voltage: 1, 2
    • acute phase and lung heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute phase and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute phase and macrophage activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute phase and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute stage and lung heart: 1, 2, 3, 4, 5
    • acute stage and macrophage activation: 1
    • acute stage and magnetic resonance: 1, 2, 3
    • local protocol and low molecular weight heparin: 1, 2, 3
    • local protocol and lung heart: 1
    • local protocol and magnetic resonance: 1, 2, 3
    • long term therapy and lung heart: 1, 2
    • long term therapy and macrophage activation: 1
    • long term therapy and magnetic resonance: 1, 2, 3, 4
    • low grade inflammation and macrophage activation syndrome: 1
    • low grade inflammation and magnetic resonance: 1